Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles

Colloids and Surfaces B: Biointerfaces

Volumn 67, Issue 2, 2008, Pages 199-204

  Xie, ShuYu ^a   Wang, SiLiang ^a   Zhao, BaoKai ^a   Han, Chao ^a   Wang, Ming ^a   Zhou, WenZhong ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Emulsification; Hydrophilic protein; Poly (lactic co glycolic acid) (PLGA); Polymeric emulsifier; Solid lipid nanoparticles (SLN)

Indexed keywords

AS MODELS; BIOLOGICAL ASSAYS; BOVINE SERUM ALBUMINS; BURST RELEASES; DOUBLE EMULSIONS; ENCAPSULATION EFFICIENCIES; GLYCOLIC ACIDS; HYDROGENATED CASTOR OIL (HCO); HYDROPHILIC; HYDROPHILIC PROTEIN; HYDROPHILIC PROTEINS; HYDROPHOBIC MATRIXES; IN VITRO RELEASES; LIPID MATRIXES; LOADING CAPACITIES; POLY (LACTIC-CO-GLYCOLIC ACID) (PLGA); POLYACRYLAMIDE GEL ELECTROPHORESES; POLYMERIC EMULSIFIER; POLYMERIC EMULSIFIERS; SODIUM DODECYL SULPHATE; SOLID LIPID NANOPARTICLES; SOLID LIPID NANOPARTICLES (SLN); SOLVENT EVAPORATION TECHNIQUES; W/O EMULSIONS;

ABS RESINS; ACIDS; BODY FLUIDS; CATALYST ACTIVITY; COLLOIDS; CONCENTRATION (PROCESS); DIFFUSERS (OPTICAL); ELECTROPHORESIS; EMULSIONS; GELATION; HYDROPHILICITY; NANOPARTICLES; NANOSTRUCTURED MATERIALS; NANOSTRUCTURES; POLYMERS; PROTEINS; SODIUM; VEGETABLE OILS; ZETA POTENTIAL;

EMULSIFICATION;

DODECYL SULFATE SODIUM; EMULSIFYING AGENT; HYDROGENATED CASTOR OIL; INSULIN; LYSOZYME; POLYGLACTIN; PROTEIN; SERUM ALBUMIN; SOLID LIPID NANOPARTICLE; SOLVENT;

ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; CONCENTRATION (PARAMETERS); COW; EMULSION; ENCAPSULATION; EVAPORATION; HYDROPHILICITY; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; ZETA POTENTIAL;

DRUG CARRIERS; EMULSIFYING AGENTS; INSULIN; LACTIC ACID; LIPIDS; MURAMIDASE; NANOPARTICLES; POLYGLYCOLIC ACID; PROTEINS; SERUM ALBUMIN, BOVINE;

BOVINAE;

EID: 55049122401     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2008.08.018     Document Type: Article

References (38)

1. Hu F.Q., Hong Y., and Yuan H. Int. J. Pharm. 273 (2004) 29-35
2. Müller R.H., and Keck C.M. J. Biotechnol. 113 (2004) 151-170
3. Lee K.Y., and Yuk S.H. Prog. Polym. Sci. 32 (2007) 669-697
4. Almeida A.J., and Souto E. Adv. Drug Deliv. Rev. 59 (2007) 478-490
5. Halter M., Antia M., and Vogel V. J. Control. Release 101 (2005) 209-222
6. Stevens P.J., and Lee R.J. Anticancer Res. 23 (2003) 439-442
7. Bjerregaard S., Wulf-Andersen L., Stephens R.W., Lund L.R., Vermehren C., Soderberg I., and Frokjaer S. J. Control. Release 71 (2001) 87-98
8. Cui Z., and Mumper R.J. Int. J. Pharm. 238 (2002) 229-239
9. Sinha V.R., and Trehan A. J. Control. Release 90 (2003) 261-280
10. Müller R.H., Maaßen S., Weyhers H., Specht F., and Lucks J.S. Int. J. Pharm. 138 (1996) 85-94
11. Wissing S.A., Kayser O., and Müller R.H. Adv. Drug Deliv. Rev. 56 (2004) 1257-2172
12. Garcia-Fuentes M., Torres D., and Alonso M.J. Int. J. Pharm. 296 (2005) 122-132
13. Garcia-Fuentes M., Prego C., Torres D., and Alonso M.J. Eur. J. Pharm. Sci. 25 (2005) 133-143
14. Müller R.H., Runge S., Ravelli V., Mehnert W., Thünemann A.F., and Souto E.B. Int. J. Pharm. 317 (2006) 82-89
15. Bekerman T., Golenser J., and Domb A. J. Pharm. Sci. 93 (2004) 1264-1270
16. Zhang N., Ping Q.N., Huang G.H., Xu W.F., Cheng Y.N., and Han X.Z. Int. J. Pharm. 327 (2006) 153-159
17. Caliceti P., Brossa A., Salmaso S., Bersani S., Elvassore N., and Bertucco A. Proc. Int. Symp. Control. Release Bioact. Mater. 33 (2006) 383-392
18. Saraf S., Mishra D., Asthana A., Jain R., Singh S., and Jain N.K. Vaccine 24 (2006) 45-56
19. Gualbert J., Shahgaldian P., and Coleman A.W. Int. J. Pharm. 257 (2003) 69-73
20. Almeida A.J., Runge S., and Müller R.H. Int. J. Pharm. 149 (1997) 255-265
21. Liu J., Gong T., Fua H.L., Wang C.G., Wang X.L., Chen Q., Zhang Q., He Q., and Zhang Z.R. Int. J. Pharm. 356 (2008) 333-344
22. Shive M.S., and Anderson J.M. Adv. Drug Deliv. Rev. 28 (1997) 5-24
23. Jiang W.L., Gupta R.K., Deshpande M.C., and Schwendeman S.P. Adv. Drug Deliv. Rev. 57 (2005) 391-410
24. Zweers Miechel L.T., Engbers Gerard H.M., Grijpma Dirk W., and Jan F.J. J. Control. Release 100 (2004) 347-356
25. Jain Rajeev A. Biomaterials 21 (2000) 2475-2490
26. Wu X.S. Artif. Cells Blood Substit. Immobil. Biotechnol. 32 (2004) 575-591
27. Steinberg D., Klinger A., Kohavi D., and Sela M.N. Biomaterials 16 (1995) 1339-1343
28. Lugtenberg B., Meijers J., Peters R., Hoek P.V.D., and Alphen L.V. FEBS Lett. 58 (1975) 254-258
29. Marks V. Clin. Chim. Acta 251 (1996) 19-24
30. Li X.H., Zhang Y.H., Yan R.H., Jia W.X., Yuan M.L., Deng X.M., and Huang Z.T. J. Control. Release 68 (2000) 41-52
31. Ishington C. Adv. Drug Deliv. Rev. 20 (1996) 131-141
32. Han F., Li S., Yin R., Liu H.Z., and Xu L. Colloids Surf. A: Physicochem. Eng. Aspects 315 (2008) 210-216
33. Liu J., Gong T., Wang C.G., Zhong Z.R., and Zhang Z.R. Int. J. Pharm. 340 (2007) 153-162
34. Deng X.M., Li X.M., and Huang Z.T. J. Control. Release 58 (1999) 123-131
35. Müller R.H., MaÈder K., and Gohla S. Eur. J. Pharm. Biopharm. 50 (2000) 161-177
36. Olbrich C., Kayser O., and Müller R.H. J. Nanoparticle Res. 4 (2002) 121-129
37. Perez C., Castellanos I.J., and Costantino H.R. J. Pharm. Pharmacol. 54 (2002) 301-313
38. Morel S., Terreno E., Ugazio E., Aime S., and Gasco M.R. Eur. J. Pharm. Biopharm. 45 (1998) 157-163